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Hymenocardia acida Tul. (Hymenocardiaceae) locally called Orupa, is traditionally used for the 
treatment of inflammation, including arthritis, rheumatic pain and toothache.  The potential anti-
inflammatory and antinociceptive activities of the aqueous leaf extract of this plant were evaluated in 
animal models. The extract (50, 100 and 200 mg/kg) significantly (P < 0.05) and dose - dependently 
inhibited carrageenan and egg albumin-induced rat paw oedema development compared with control 
group. At 3 h of post-carrageenan administration, the highest dose of the extract (200 mg/kg, p.o) 
inhibited oedema formation by 66.67%. The reference drug used, indomethacin (10 mg/kg, p.o), gave an 
inhibition of 72.22%. The inhibitory activity shown by the aqueous leaf extract of H. acida over a period 
of 6 h in the carrageenan and 3 h in the egg albumin-induced paw inflammation models was comparable 
to that exhibited by the reference drugs used, indomethacin and cyproheptadine (10 mg/kg, p.o). The 
extract elicited a significant analgesic activity in the tail immersion test as evidenced by the increase in 
latency time in seconds as compared with the control at the end of 20 min. In the acetic acid-induced 
writhing model, the extract showed a dose-dependent reduction in the number of writhes at 50, 100 and 
200 mg/kg when compared to the control group. The 200 mg/kg dose  produced a complete protective 
effect, as no abdominal constriction was observed. The results obtained in this study provide some 
justification for the folkloric uses of H. acida as a remedy for relieving pain and inflammation.     
 





Inflammation is a complex multistep process comprising 
a dynamic cascade of biological phenomena, which can 
be subdivided into several stages and phases (Drozdova 
and Bubenchikov, 2005). Proinflammatory molecules like 
TNFα (tumor necrosis factor alpha), certain interleukins, 
prostaglandins and even pathogenic concentration of 
nitric oxide are instrumental in raising inflammatory 
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inflammatory drugs target these mediators at different 
levels, yet they lack specificity and their untoward effects 
restrict their long-term use (Dhikav et al., 2002). Hence, 
there is a constant demand for better therapeutic altern-
atives.  
Many medicinal plants have been investigated for novel 
drugs or templates for the development of new thera-
peutic agents. Hymenocardia acida Tul. (Hymenocar-
diaceae), popularly known as ‘Orunpa’ has been used in 
folk medicine for many years in South-West, Nigeria and 
some other parts of tropical Africa. Decoction or infusion 





with other plant species are used for chest complaints, 
abdominal and menstrual pains and as poultices on 
abscesses and tumuors (Burkill, 1994). The leaf is taken 
as snuff for headache or applied topically for rheumatic 
pains and toothache. Ethnobotanical survey further dis-
closed the folkloric uses of the leaves of the plant 
amongst others in inflammatory disorder, especially 
arthritic condition (Sofidiya et al., 2007).    
The anti-inflammatory activity of the ethanolic crude 
extract of the stem bark of H. acida has previously been 
investigated (Sackeyfio, 1998). In the study, the ethanolic 
crude extract of the stem bark of this plant exhibited anti-
inflammatory activity in adjuvant-induced arthritis and 
bovine serum albumin-induced pinnal inflammation res-
pectively. However, there is no scientific report presently 
on the anti-inflammatory activity of the leaves of this plant 
which could possibly explain the use in some painful 
disorders and rheumatic diseases. Therefore, the main 
objective of the present study is to evaluate the anti-
inflammatory and antinociceptive potential of the aqueous 
extract of H. acida leaves using in vivo experimental 
models in rats and mice.   
 
 




The leaves of H. acida were collected in January 2004 at Olokemeji 
Forest Reserve (7.42 N 3.55 E), Ogun State, Nigeria. The plant was 
authenticated at the Forestry Research Institute of Nigeria, Ibadan, 
Nigeria, by Mr. Felix Usang. Voucher specimens (FHI 38672) were 
prepared and deposited at the herbaria of both the Institute and at 
the Pharmacognosy Department, Faculty of Pharmacy, University 
of Lagos.  
 
 
Preparation of crude extract.  
 
The leaves were air dried at room temperature, reduced to coarse 
powder, and a portion (250 g) was extracted with 2.5 L of distilled 
water on a shaker overnight at room temperature. The extract was 
filtered through whatman No.1 filter paper and the filtrate concen-
trated in a lyophilizer (freeze drier model B67 New Brunswick 
Scientific Co. Inc., New Brunswick N.J. USA). The yield of the 
extract was 11.4% w/w. The extract was then stored in the 
refrigerator for further use. Before use, a stock solution of 50 mg/ml 
was prepared for pharmacological experiments. 
 
 
Preliminary chemical tests 
 
Phytochemical screening of the powdered plant material was 
carried out to ascertain the qualitative chemical composition of the 
plant using commonly employed colour reactions and thin layer 
chromatography to identify the major constituents. The procedure 
was done according to the methods of Harborne (1998) and 
Asongalem et al. (2004).    
 
 
Experimental animals  
 
Male and female Wistar rats weighing 120 - 180 g were used to 
study the effect of the  extract  on  inflammation,  while  albino  mice 




(male) weighing between 20 - 35 g were used for analgesic activity 
studies. The animals were obtained from the Nigerian Institute of 
Medical Research, Lagos, Nigeria and were kept at the Laboratory 
Animal Center of the College of Medicine, University of Lagos, 
Nigeria. They were maintained under laboratory conditions of 
temperature, humidity and light and were allowed free access to 
food (standard pellet diet, Pfizer Feeds, Plc, Lagos) and water ad 
libitum. All the animals were acclimatized to the laboratory 
environment for 3 weeks before the experiment. The experimental 
protocol was approved by the experimentation ethics committee on 
animal use of the College of Medicine, University of Lagos, Nigeria.    
 
 
Anti-inflammatory studies  
 
Carrageenan-induced rat paw model  
 
Wistar rats of both sexes (120 - 180 g) were used in this study. The 
animals were divided into five groups of five rats each. A volume of 
0.1 ml of 1% w/v carrageenan (Sigma-Aldrich Chemie Gmbh, 
Steinheim, Denmark) in distilled water, was injected into the sub-
plantar region of the right hind paw of rats (Akindele and Adeyemi, 
2007). The linear paw circumference was measured immediately 
after carrageenan injection (0 h) and at intervals of 1, 2, 3, 4, 5 and 
6 h using the cotton thread method (Bamgbose and Noamesi, 
1981). Distilled water (5 ml/kg, p.o.) the aqueous extract (50, 100 
and 200 mg/kg, p.o), and indomethacin (10 mg/kg, p.o) were 
administered orally 1 h before carrageneenan injection. The mean 
increase in paw swelling was measured and the percentage 
inhibition of the inflammation was calculated from the formula:   
  
          (Ct − C0) control − (Ct − C0) treated   
% Inhibition =               × 100 
                                       (Ct − C0) control                             
 
 
Where Ct is the paw circumference at t time after carrageenan 
administration and C0 is the paw circumference before carrageenan 
administration.    
 
 
Egg albumin-induced rat paw oedema   
 
Wistar rats of both sexes (120 - 180 g) were used for this assay. 
The rats were divided into five groups of five animals each. Rats 
were pretreated with the vehicle (distilled water, 5 ml/kg, p.o), the 
extract (50, 100 and 200 mg /kg, p.o) and cyproheptadine (10 
mg/kg, p.o), 1 h before eliciting paw oedema. Acute inflammation 
was induced by injecting 0.1 ml of 0.1% freshly prepared solution of 
egg albumin into the subplantar region of the right hind paw of rats 
(Ojewole, 2006). The linear paw circumference was measured 
using the cotton thread method (Bamgbose and Noamesi, 1981) for 






Acetic acid-induced abdominal writhing in mice  
 
The writhing test was performed as described by Atta and Alkofahi 
(1998). Adult albino mice (22 - 32 g) were divided into five groups of 
five animals each. The animals were pretreated with the vehicle 
(distilled water 5 ml/kg, p.o), the aqueous extract of H. acida (50, 
100 and 200 mg/kg, p.o.), and indomethacin (10 mg/kg, p.o.). This 
was followed by intraperitoneal injection of 1% (v/v) acetic acid (10 
mg/kg) after 60 min. The mice were then placed in an observation 
box. 5 min after the intraperitoneal injection of acetic acid, the 
number of writhes  during  the  following  20 min  was  counted. The  




Table 1. Effect of aqueous leaf extract of H. acida on carrageenaan-induced rat paw oedema.   
    
Treatment Dose (mg/kg) 0 1 h 2 h 3 h 4 h 5 h 6 h 
Control  1.86 ± 0.06 1.98 ± 0.13 2.06 ± 0.10 2.2 2 ± 0.06 2.12 ± 0.06 2.18 ± 0.06 2.14 ± 0.04 
H. acida  50 1.90 ± 0.03 
 
2.00 ± 0.03 
(16.67) 
2.06 ± 0.02 
(20.00) 
2.12 ± 0.07 
(38.89) 
2.04 ± 0.02 
(46.15) 
2.00 ± 0.05 
(68.75) 
1.98 ± 0.02* 
(71.43) 
100 1.76 ± 0.02 
 
1.84 ± 0.02 
(33.33) 
1.88 ± 0.04 
(40.00) 
1.94 ± 0.07* 
(50.00) 
1.86 ± 0.06* 
(61.54) 
1.84 ± 0.08* 
(75.00) 
1.82 ± 0.07* 
(78.57) 
200 1.78 ± 0.07 
 
1.86 ± 0.06 
(33.33) 
1.88 ± 0.02 
(50.00) 
1.90 ± 0.04* 
(66.67) 
1.86 ± 0.05* 
(69.23) 
1.84 ± 0.05* 
(81.25) 
0.82 ± 0.04* 
(85.71) 
Indomethacin 10 1.78 ± 0.04 1.84 ± 0.05 
(50.00) 






1.82 ± 0.04* 
(87.50) 
1.80 ± 0.05* 
(92.86) 
 
Table showing mean increases in carrageenan-induced paw oedema (cm) with time after distilled water, H. acida (50, 100 and 200 mg/kg) or indomethacin administration to rats. 




number of writhes in each drug treated group was com-
pared to that of the saline-treated group (control).          
 
 
Tail immersion test  
 
Distilled water (5 ml/kg, p.o), the extract at doses of 50, 
100 and 200 mg/kg (p.o.) and indomethacin (10 mg/kg, 
p.o) were administered to mice divided into groups of five 
animals each. 30 min post-treatment, the tail (up to one-
third) was immersed in a water bath maintained at 55°C. 
The reaction time (in sec) was taken as the time when the 
animals withdrew their tails completely from the hot water 
in the bath (Parimaladevi et al., 2003). The response of the 
extract and indomethacin treated groups were compared 
with those of the animals in the distilled water-treated 





Data obtained were expressed as mean ± standard error of 
mean (SEM). Student’s t-test was used to compare test 
and control group values. Differences in the test versus 
control values were considered to be statistically significant 
at P ≤ 0.05.   
RESULTS AND DISCUSSION  
 
Anti-inflammatory    
 
The aqueous extract of the leaves of H. acida was 
evaluated in rat paw oedema models induced by 
carrageenan and egg albumin. The extract pro-
duced a significant and dose-dependent inhibition 
of carrageenan induced inflammation (Table 1). At 
3 h post-carrageenan administration, the highest 
dose of the extract (200 mg/kg) inhibited oedema 
development by 66.67%, while indomethacin (10 
mg/kg, p.o), a cyclooxygenase inhibitor used in 
this assay as a reference, gave an inhibition of 
72.22%. The extract (50, 100 and 200 mg/kg) also 
significantly (P < 0.05) and dose-dependently 
inhibited egg albumin-induced rat paw oedema 
compared with the control group. At 3 h, the 
percentage inhibition of 90% was observed with 
the dose 200 mg/kg of H. acida while cypro-
heptadine (10 mg/kg) produced 100% inhibition 
(Table 2).     
As shown in Tables 1 and 2, the aqueous leaf 
extract of H. acida effectively suppressed the 
oedema produced by carrageenan and egg albumin 
in a dose-dependent manner. The carrageenan-
induced rat paw oedema test has significant pre-
dictive value for anti-inflammatory agents acting 
by inhibiting the mediators of acute inflammation 
(Olajide et al., 2000). In the time course of oede-
matous inflammation induced by carrageenan, it 
has been shown that three main mediators are 
responsible for acute and chronic inflammatory 
reactions (Kasahara et al., 2002). The first phase 
of oedema is attributed to the release of hista-
mine, serotonin or bradykinin by local cells. After a 
couple of hours, there is liberation of prosta-
glandins (Morris, 2003). This indicates that the 
extract possibly exhibits its anti-inflammatory 
action by inhibiting the synthesis, release or action 
of inflammatory mediators including histamine, 
serotonin and prostaglandin known to mediate 
acute inflammation induced by phlogistic agents, 
that are likely also involved  in  both  egg  albumin  




Table 2. Effect of aqueous leaf extract of H. acida on egg albumin-induced rat paw oedema.   
 
Treatment Dose (mg/kg) 0 30 min 60 min 90 min 120 min 150 min 180 min 
Control  1.86 ± 0.05 2.08 ± 0.06 2.12 ± 0.06 2.18 ± 0.05 2.20 ± 0.03 2.10 ± 0.05 2.06 ± 0.02 
H. acida 50 1.92 ± 0.05 
 
2.12 ± 0.04 
(9.09) 
2.12 ± 0.07 
(23.08) 
2.10 ± 0.04 
(43.75) 
2.08 ± 0.06 
(52.94) 
2.02 ± 0.08 
(58.33) 
2.00 ± 0.00 
(60.00) 
 100 1.92 ± 0.05 
 
2.06 ± 0.05 
(36.36) 
2.06 ± 0.04 
(46.15) 
2.04 ± 0.05* 
(62.50) 
2.02 ± 0.04* 
(70.59) 
1.98 ± 0.06* 
(75.00) 
1.96 ± 0.05* 
(80.00) 
 200 1.86 ± 0.05 
 
1.98 ± 0.05 
(45.45) 
1.98 ± 0.04 
(53.85) 
1.96 ± 0.05* 
(68.75) 
1.94 ± 0.04* 
(76.47) 
1.90 ± 0.06* 
(83.33) 
1.88 ± 0.05* 
(90.00) 
Cyproheptadine 10 1.90 ± 0.09 
 
2.02 ± 0.04 
(45.45) 
2.00 ± 0.04 
(61.54) 
1.98 ± 0.02* 
(75.00) 
1.96 ± 0.02* 
(82.35) 
1.92 ± 0.06* 
(91.67) 
1.90 ± 0.04* 
(100.00) 
 
Table showing mean increases in egg albumin-induced paw oedema (cm) with time after distilled water, H. acida (50, 100 and 200 mg/kg) or cyproheptadine administration to rats. 




Table 3. Effect of aqueous leaf extract of H. acida on acetic acid-induced writhing in mice.    
    
Group Dose (mg/kg) Number of writhing Inhibition (%) 
Control - 61.75 ± 3.01 - 
H. acida 50 39.50 ± 4.44* 36.0 
100 25.00 ± 2.61* 59.5 
200 0.00* 100 
Indomethacin 10 17.50 ± 1.04* 71.7 
 
The standard acetic acid-induced writhing in mice was employed. Acetic acid was intraperitoneally 
injected (1 % v/v) and extract and indomethacin were orally administered. Each value represents mean 
±SEM or percentage inhibition of pain as compared to control animals, (n = 5). * P < 0.05 significantly 




and carrageenan induced acute oedema (Haiping, 
2008). 
The second phase of carrageenan-induced 
inflammation is also related to neutrophil 
infiltration and production of reactive free radical 
species derived from them (Dordevic et al., 2007). 
From our previous study H. acida demonstrated 
significant antioxidant potential in vitro (Sofidiya et 
al., 2009) indicating that the extract may also 
exert its anti-inflammatory effect partly through the 






Oral administration of the extract and indome-
thacin significantly decreased the number of 
acetic acid-induced writhes in mice compared to 
the control (P < 0.05). The extract showed a dose-
dependent effect at 50, 100 and 200 mg/kg. At 
200 mg/kg, there was complete protective effect, 
as no abdominal constriction was observed (Table 
3). The acetic acid-induced abdominal constriction 
test is non-specific, as it does not indicate whether 
the activity was central and or peripheral (Chan et 
al., 1995; Magaji et al., 2008). However, the method 
is very sensitive and useful to detect the pharma-
cological activity of compounds in comparison 
with   other  methods  like  the  tail-immersion  test  




Table 4. Effect of aqueous leaf extract of H. acida on tail immersion test in mice. 
 
Group Dose (mg/kg) Pre-treatment Post-treatment Inhibition (%) 
Control - 2.80 ± 1.25 2.60 ± 1.16 - 
H. acida 50 3.00 ± 1.34 4.00 ± 1.79 33.33 
100 4.00 ± 1.79 6.20 ± 2.77* 55.00 
200 4.00 ± 1.79 7.40 ± 3.31* 85.00 
Indomethacin 10 3.20 ± 1.43 5.60 ± 2.50* 75.00 
 
Table showing the reaction time (in seconds) of tail withdrawal from water maintained at 55 
o
C by mice before 
and after treatment with distilled water, H. acida (50, 100 and 200 mg/kg), or indomethacin. Values are mean 




(Bentley et al., 1981). With respect to the writhing test, 
the potent inhibitory effect exerted by the extract suggests 
that its analgesic effect may be peripherally mediated 
(Okpo et al., 2001). The observed analgesic effect of the 
extract can possibly be partly attributed to its anti-
inflammatory effect. This is because in the visceral pain 
model, the processor releases arachidonic acid via cyclo-
oxygenase and prostaglandin biosynthesis which plays a 
role in the nociceptive mechanism (Franzotti et al., 2002).   
The extract also had a significant effect in the acute 
pain model as demonstrated in the tail immersion test. 
This was evidenced by increase in latency time in 
seconds compared with the control at the end of 20 min 
(Table 4). This effect of the extract indicates that it might 
be centrally acting, as centrally acting analgesic drugs 
elevate pain threshold of animals towards heat and 





The phytochemical analyses revealed the presence of 
flavonoids, saponins, alkaloids, glycosides, tannins, triter-
penoids and steroidal nucleus. A variety of in vitro and in 
vivo experiments have shown that flavonoids, tannins, 
triterpenoids and other secondary plant metabolites 
possess analgesic and anti-inflammatory properties in 
various experimental animal models (Yuan et al., 2006; 
Salminen et al., 2008;  Garcı´a-Lafuente et al., 2009). An 
alkaloid, hymenocardine and five triterpenoid-friedelan-3-
one, betulinic acid, lupeol, stigmasterol and sitosterol 
have been reported isolated and identified from the stem 
bark of this plant (Pais et al., 1968; Mpiana et al., 2009). 
Thus, these compounds may contribute to the observed 
anti-inflammatory and antinociceptive effects of H. acida 
Based on the results obtained in this study, it could be 
concluded that the aqueous leaf extract of H. acida 
demonstrated significant anti-inflammatory and anti-
nociceptive activities, providing a scientific basis to 
explain, in part, the popular use of the plant in Nigerian 
folk medicine. It also suggests that the extract contains 
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